Implications of Bim in abnormal hematopoiesis of chronic myelogenous leukemia (CML).

被引：0
|
作者：
Kuribara, R
Honda, H
Shinjyo, TA
Hirai, H
Ozawa, K
Inaba, T
机构：
[1] Jichi Med Sch, Dept Hematol, Minami Kawachi, Tochigi, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima 730, Japan
[3] Univ Ryukyus, Dept Med 2, Okinawa, Japan
[4] Univ Tokyo, Dept Hem Onc, Tokyo, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1952
引用
收藏
页码：467A / 467A
页数：1
相关论文
共 50 条
  • [1] Implications of BIM, a BH3-only member of Bcl-2 superfamily, in abnormal hematopoiesis of chronic myelogenous leukemia.
    Kuribara, R
    Honda, H
    Shinjyo, T
    Inukai, T
    Sugita, K
    Nakazawa, S
    Hirai, H
    Ozawa, K
    Inaba, T
    BLOOD, 2000, 96 (11) : 347A - 347A
  • [2] Chronic Myelogenous Leukemia (CML) in the elderly
    Balducci, Lodovico
    Dolan, Dawn
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01):
  • [3] CLINICAL IMPLICATIONS OF CHROMOSOME-22 BREAKPOINTS IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    LEIBOWITZ, D
    ARLIN, Z
    SHAPIRO, LR
    MEARS, JG
    SILVER, R
    SCHAEFERREGO, K
    CLINICAL RESEARCH, 1988, 36 (03): : A413 - A413
  • [4] The Symptom Burden of Chronic Myelogenous Leukemia (CML)
    Williams, Loretta A.
    Ault, Patricia
    Wang, Xin Shelley
    Cleeland, Charles S.
    Mendoza, Tito R.
    Mobley, Gary M.
    Cortes, Jorge E.
    BLOOD, 2008, 112 (11) : 839 - 840
  • [5] MODERN MANAGEMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    FELDMAN, EJ
    ARLIN, ZA
    CANCER INVESTIGATION, 1988, 6 (06) : 737 - 742
  • [6] BONE INVOLVEMENT IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    TRIPATHY, K
    GOMEZ, GA
    PARK, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 153 - 153
  • [7] AN ATYPICAL PRESENTATION OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    Ashraf, Farhan
    Ribbizi-Akhtar, Iole
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S548 - S549
  • [8] New therapeutic approaches in acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML)
    Marie, JP
    BULLETIN DU CANCER, 1997, 84 (04) : 451 - 452
  • [9] PSYCHOLOGICAL PROFILE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS
    Bajenova, P.
    Lomaia, E.
    Zaritskey, A.
    Schelkova, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 543 - 544
  • [10] TIMING OF MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    SEGEL, GB
    LICHTMAN, MA
    SIMON, W
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 220 - 220
12345